Taking prescription medication safely involves more than following the correct dosage. Some medicines require regular examinations, laboratory tests, or other health assessments to identify possible side effects before they become serious. One medication that requires particular attention is hydroxychloroquine, which is commonly prescribed for autoimmune diseases and certain types of malaria. 
Although many patients tolerate this medicine well, long-term treatment can sometimes affect the eyes, heart, blood cells, and other parts of the body. Appropriate monitoring helps healthcare professionals identify potential complications, evaluate treatment effectiveness, and determine whether the prescribed dose remains suitable.
For patients taking this medicine for rheumatoid arthritis, lupus, or another inflammatory condition, monitoring is an important part of maintaining long-term health. It can also provide reassurance by helping doctors identify problems early, often before noticeable symptoms develop.
Understanding which tests are necessary, how frequently they should be performed, and what symptoms require medical attention can help patients participate more confidently in their treatment.
Why Does Hydroxychloroquine Require Monitoring?
Hydroxychloroquine is an antimalarial medication that also modifies certain immune system activities.
Doctors commonly prescribe it for conditions such as:
-
Systemic lupus erythematosus.
-
Rheumatoid arthritis.
-
Discoid lupus.
-
Certain inflammatory skin disorders.
-
Prevention and treatment of susceptible malaria infections.
For autoimmune conditions, treatment may continue for several years. Although the medicine can provide important benefits, prolonged exposure may increase the risk of certain adverse effects.
Monitoring helps doctors balance these benefits against possible risks.
Detecting Eye Damage
One of the most important reasons for monitoring is the possibility of retinal toxicity.
The retina is the light-sensitive tissue located at the back of the eye. Long-term exposure to the medication can sometimes damage retinal cells, potentially causing permanent visual impairment.
Early retinal damage may not produce noticeable symptoms.
Regular eye examinations can identify structural changes before patients experience significant vision loss.
Checking for Heart Problems
In rare cases, the medication can affect the electrical activity of the heart or cause damage to the heart muscle.
Monitoring may be necessary for patients with existing heart disease, abnormal heart rhythms, or other risk factors.
Reviewing Blood and Organ Function
Some patients may require blood tests or assessments of kidney and liver function.
These examinations can help identify medical conditions that influence medication safety and determine whether treatment adjustments are necessary.
Evaluating Treatment Effectiveness
Monitoring is not limited to identifying side effects.
Doctors also assess whether the medicine is controlling symptoms, reducing inflammation, preventing disease flare-ups, and improving quality of life.
If treatment is not providing sufficient benefit, the healthcare professional may consider a different approach.
Eye Monitoring: The Most Important Part of Long-Term Treatment
Eye monitoring is particularly important because retinal damage caused by this medication can be permanent.
The American Academy of Ophthalmology (AAO) published revised screening recommendations in November 2025. These recommendations emphasize baseline examinations, retinal imaging, and regular follow-up.
1. Baseline Eye Examination
Patients should arrange a baseline eye examination soon after beginning treatment.
This examination establishes a reference point for future comparisons and helps identify existing eye conditions that could affect screening results.
A baseline assessment generally includes:
-
A comprehensive eye examination.
-
Optical coherence tomography.
-
Wide-pattern fundus autofluorescence.
-
An assessment of existing retinal abnormalities.
If a patient already has retinal disease, the ophthalmologist can determine whether additional precautions or alternative treatments should be considered.
2. Optical Coherence Tomography (OCT)
Optical coherence tomography is one of the most important tests for detecting early retinal toxicity.
It uses light waves to produce detailed cross-sectional images of the retina.
The test can reveal subtle changes in retinal layers before patients experience noticeable vision problems.
OCT is painless, noninvasive, and generally takes only a few minutes.
3. Fundus Autofluorescence (FAF)
Fundus autofluorescence is another important retinal imaging technique.
It helps specialists examine the health of the retinal pigment epithelium, a layer of cells that supports normal retinal function.
Abnormal imaging patterns may indicate early medication-related damage.
Wide-pattern imaging is particularly useful because retinal toxicity can affect areas beyond the central retina.
4. Visual Field Testing
Visual field testing measures how well a person can detect objects in different areas of their field of vision.
During the examination, patients focus on a central target and respond when small lights appear.
The test can identify areas of reduced vision that might otherwise go unnoticed.
The AAO's updated guidance considers visual field testing an additional or confirmatory test rather than the primary screening method.
5. Multifocal Electroretinography
Multifocal electroretinography, or mfERG, measures electrical responses from different retinal areas.
It may help confirm suspected retinal toxicity when other examination results are uncertain.
This test is more specialized and is not routinely necessary for every patient.
The ophthalmologist determines whether additional testing is appropriate based on the patient's risk factors and initial screening results.
How Often Should Hydroxychloroquine Monitoring Be Performed?
The monitoring schedule depends on how long the patient has been taking the medicine, the prescribed dosage, and individual risk factors.
The following table provides a general overview.
|
Monitoring assessment |
General timing |
|---|---|
|
Baseline eye examination |
Soon after starting treatment |
|
Annual retinal screening |
Generally recommended during continued treatment |
|
Early eye screening |
May be deferred during the first five years if significant risk factors are absent |
|
Kidney function |
Before treatment and periodically as clinically appropriate |
|
Liver function |
As appropriate based on medical history and clinical circumstances |
|
Blood tests |
When indicated by symptoms, existing conditions, or the treating clinician |
|
Heart assessment |
When cardiac risk factors, symptoms, or interacting medications warrant it |
|
Treatment effectiveness |
During routine medical appointments |
These are general recommendations. A healthcare professional may recommend a different schedule depending on the patient's health and treatment needs.
What Other Tests May Be Necessary?
Although eye examinations receive the most attention, monitoring may also involve other aspects of health.
Kidney Function Tests
Kidneys help remove many medications and their metabolites from the body.
Reduced kidney function can increase exposure to the medicine and raise the risk of adverse effects, including retinal toxicity.
Doctors may use blood tests such as serum creatinine and estimated glomerular filtration rate (eGFR) to assess kidney function.
Patients with chronic kidney disease may require more frequent assessments or a dosage review.
Liver Function Tests
The liver plays an important role in processing medications.
Liver function tests may be appropriate for patients with existing liver disease, abnormal previous results, or other clinical concerns.
These tests may include measurements of liver enzymes and bilirubin.
Not every patient requires frequent liver testing solely because they are taking this medication. The schedule should reflect individual medical circumstances.
Complete Blood Count (CBC)
A complete blood count measures different types of blood cells, including:
-
Red blood cells.
-
White blood cells.
-
Platelets.
Rarely, the medication can affect blood cell production.
A doctor may recommend a CBC when clinically appropriate, particularly if a patient has an existing blood disorder or develops unexplained symptoms.
Patients experiencing unusual bruising, persistent infections, or unexplained fatigue should discuss these symptoms with their healthcare professional.
Blood Sugar Monitoring
The medicine can sometimes lower blood glucose levels.
Patients with diabetes may need additional monitoring, especially if they use insulin or other glucose-lowering medications.
Symptoms such as sweating, trembling, confusion, dizziness, or sudden weakness may indicate low blood sugar.
Patients should follow their diabetes management plan and seek medical advice if these symptoms occur repeatedly.
Does Hydroxychloroquine Need Heart Monitoring?
Not every patient requires routine heart testing, but some people may benefit from additional cardiac assessments.
The medication can occasionally affect the electrical activity of the heart, including prolongation of the QT interval.
In rare cases, long-term use has also been associated with cardiomyopathy, a condition that affects the heart muscle.
Electrocardiogram (ECG)
An electrocardiogram records the electrical activity of the heart.
Doctors may recommend an ECG for patients with:
-
Existing heart disease.
-
A history of abnormal heart rhythms.
-
Unexplained fainting.
-
Other medications that prolong the QT interval.
-
Additional cardiac risk factors.
An ECG can help identify certain electrical abnormalities, although it does not detect every possible heart complication.
Symptoms That Require Medical Attention
Patients should seek prompt medical assessment if they experience:
-
Fainting or near-fainting.
-
Unexplained shortness of breath.
-
A persistent irregular heartbeat.
-
New chest discomfort.
-
Unusual swelling in the legs.
These symptoms can have several causes. They should not automatically be attributed to the medication, but they require appropriate evaluation.
How Is Treatment Effectiveness Monitored?
Monitoring also helps determine whether the medication is providing the intended benefits.
For rheumatoid arthritis, doctors may assess joint swelling, pain, stiffness, and physical function.
For lupus, they may evaluate fatigue, skin symptoms, joint discomfort, disease flare-ups, and other organ-related symptoms.
Depending on the condition, doctors may also use blood tests to assess inflammation or disease activity.
The purpose is to determine whether treatment is controlling the underlying condition adequately.
If symptoms continue or become worse, the doctor may review the dosage, investigate other causes, or consider additional treatment.
Patients should not assume that persistent symptoms mean they should increase their medication dose.
What Factors Increase the Need for Closer Monitoring?
Some patients have a higher risk of medication-related complications.
Important risk factors include:
Higher Daily Dosage
Retinal toxicity risk increases when the daily dose exceeds recommended limits.
The AAO recommends a daily dosage of no more than 5 milligrams per kilogram of actual body weight for most patients, with additional considerations for severe obesity.
The prescribing doctor should regularly review the dose, particularly if body weight changes significantly.
Long-Term Treatment
The risk of retinal toxicity generally increases with treatment duration.
Patients who have taken the medicine for five years or longer should ensure that appropriate annual retinal screening is arranged.
Kidney Disease
Reduced kidney function can increase medication exposure.
Patients with kidney impairment may need more frequent monitoring.
Tamoxifen Use
Tamoxifen is associated with an increased risk of retinal toxicity when used alongside this medication.
Patients taking both medicines should inform their doctors and ophthalmologists.
Starting Treatment at an Older Age
Beginning treatment at an older age is another recognized retinal risk factor.
These patients may require closer monitoring from the beginning of treatment.
What Symptoms Should Patients Report?
Monitoring is not limited to scheduled appointments.
Patients should also pay attention to new or unexplained symptoms between visits.
Important symptoms include:
-
Blurred central vision.
-
Difficulty reading.
-
Distorted images.
-
New dark spots in vision.
-
Unexplained fainting.
-
Irregular heartbeat.
-
Severe muscle weakness.
-
Unusual bruising.
-
Persistent infections.
Sudden vision loss, flashes of light, or a curtain-like shadow across the vision requires urgent eye assessment.
Patients should not wait until their next scheduled appointment if they develop concerning symptoms.
Do not stop taking the medicine independently. The prescribing doctor should evaluate the potential risks of continuing treatment against the benefits of controlling the underlying condition.
Conclusion
Hydroxychloroquine requires appropriate monitoring to ensure that its benefits continue to outweigh its potential risks. Although many patients tolerate the medicine well, long-term treatment can sometimes cause complications affecting the retina, heart, blood cells, and other parts of the body.
Eye monitoring is particularly important because retinal toxicity may develop without noticeable symptoms and can cause permanent vision loss. A baseline eye examination, followed by appropriate retinal imaging and regular screening, helps identify early changes before significant damage occurs.
Other monitoring measures may include kidney function tests, liver assessments, blood counts, blood sugar checks, and cardiac evaluations when clinically appropriate. The exact schedule depends on the patient's medical history, dosage, treatment duration, and individual risk factors.
Patients can also contribute to safer treatment by following their prescribed dosage, attending medical appointments, reporting unusual symptoms, and informing their healthcare professionals about other medications.
Regular monitoring does not mean that serious complications are inevitable. Instead, it provides a practical way to identify potential problems early and make informed treatment decisions.
When prescribed appropriately and monitored carefully, hydroxychloroquine can remain a valuable treatment for many patients with autoimmune diseases and certain malaria infections.